ATHA Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | San Martin Javier | officer: CHIEF MEDICAL OFFICER | 400,000 | A-Award | A | 400,000 | 2.06 | 824,000.00 |
| 2024-04-15 | San Martin Javier | 0 | 0 | 0.00 | 0.00 | |||
| 2024-02-15 | Litton Mark James | director, officer: CEO | 650,000 | A-Award | A | 650,000 | 3.66 | 2,379,000.00 |
| 2024-02-14 | Worthington Mark | officer: GENERAL COUNSEL | 220,000 | A-Award | A | 220,000 | 3.26 | 717,200.00 |
| 2024-02-14 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 220,000 | A-Award | A | 220,000 | 3.26 | 717,200.00 |
| 2024-02-14 | Gengos Andrew | officer: CFO AND CHIEF BUSINESS OFFICER | 280,000 | A-Award | A | 280,000 | 3.26 | 912,800.00 |
| 2024-02-14 | Lenington Rachel | officer: COO AND CDO | 300,000 | A-Award | A | 300,000 | 3.26 | 978,000.00 |
| 2024-01-04 | Gengos Andrew | officer: CFO AND CHIEF BUSINESS OFFICER | 85,012 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2024-01-05 | Gengos Andrew | officer: CFO AND CHIEF BUSINESS OFFICER | 83,804 | S-Sale | D | 1,208 | 2.91 | 3,515.00 |
| 2024-01-04 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 82,668 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2024-01-05 | CHURCH KEVIN | officer: CHIEF SCIENTIFIC OFFICER | 80,256 | S-Sale | D | 2,412 | 2.91 | 7,019.00 |
| 2024-01-04 | MOEBIUS HANS | officer: Chief Medical Officer | 91,482 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2023-01-04 | Gengos Andrew | officer: See Below | 85,012 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2023-01-05 | Gengos Andrew | officer: See Below | 83,804 | S-Sale | D | 1,208 | 2.91 | 3,515.00 |
| 2024-01-04 | Litton Mark James | director, officer: Chief Executive Officer | 149,217 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2024-01-05 | Litton Mark James | director, officer: Chief Executive Officer | 144,397 | S-Sale | D | 4,820 | 2.91 | 14,026.00 |
| 2024-01-04 | Worthington Mark | officer: General Counsel | 36,864 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2024-01-05 | Worthington Mark | officer: General Counsel | 34,452 | S-Sale | D | 2,412 | 2.91 | 7,019.00 |
| 2023-05-18 | Worthington Mark | officer: General Counsel | 26,864 | A-Award | A | 7,767 | 2.41 | 18,718.00 |
| 2023-01-04 | CHURCH KEVIN | officer: Chief Scientific Officer | 82,668 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2023-01-05 | CHURCH KEVIN | officer: Chief Scientific Officer | 80,256 | S-Sale | D | 2,412 | 2.91 | 7,019.00 |
| 2023-11-20 | CHURCH KEVIN | officer: Chief Scientific Officer | 72,668 | A-Award | A | 3,397 | 1.34 | 4,552.00 |
| 2023-05-18 | CHURCH KEVIN | officer: Chief Scientific Officer | 69,271 | A-Award | A | 809 | 2.41 | 1,950.00 |
| 2024-01-04 | Lenington Rachel | officer: Chief Operating Officer | 15,807 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2024-01-05 | Lenington Rachel | officer: Chief Operating Officer | 13,395 | S-Sale | D | 2,412 | 2.91 | 7,019.00 |
| 2023-12-29 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 5,402,964 | P-Purchase | A | 163,954 | 2.38 | 390,211.00 |
| 2023-12-28 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 5,239,010 | P-Purchase | A | 409,598 | 2.44 | 999,419.00 |
| 2023-12-27 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 4,829,412 | P-Purchase | A | 32,134 | 2.28 | 73,266.00 |
| 2023-06-07 | Gengos Andrew | officer: See Below | 80,012 | P-Purchase | A | 11,719 | 3.44 | 40,308.00 |
| 2023-06-07 | Gengos Andrew | officer: See Below | 68,293 | P-Purchase | A | 2,859 | 3.40 | 9,721.00 |
| 2023-06-07 | Gengos Andrew | officer: See Below | 65,434 | P-Purchase | A | 422 | 3.36 | 1,417.00 |
| 2023-06-05 | Gengos Andrew | officer: See Below | 65,012 | P-Purchase | A | 10,000 | 3.02 | 30,154.00 |
| 2023-06-05 | Gengos Andrew | officer: See Below | 55,012 | P-Purchase | A | 10,000 | 3.00 | 29,999.00 |
| 2023-06-05 | Gengos Andrew | officer: See Below | 45,012 | P-Purchase | A | 10,000 | 3.00 | 29,997.00 |
| 2023-06-05 | Gengos Andrew | officer: See Below | 35,012 | P-Purchase | A | 15,000 | 3.00 | 45,000.00 |
| 2023-06-02 | Gengos Andrew | officer: See Below | 20,012 | P-Purchase | A | 3,418 | 2.95 | 10,066.00 |
| 2023-06-02 | Gengos Andrew | officer: See Below | 16,594 | P-Purchase | A | 6,582 | 2.86 | 18,823.00 |
| 2023-06-02 | Gengos Andrew | officer: See Below | 10,012 | P-Purchase | A | 10,012 | 2.75 | 27,533.00 |
| 2023-06-02 | MOEBIUS HANS | officer: Chief Medical Officer | 81,482 | M-Exempt | A | 7,882 | 1.35 | 10,641.00 |
| 2023-05-18 | MOEBIUS HANS | officer: Chief Medical Officer | 73,600 | A-Award | A | 7,764 | 2.41 | 18,711.00 |
| 2023-06-02 | MOEBIUS HANS | officer: Chief Medical Officer | 0 | M-Exempt | D | 7,882 | 1.35 | 10,641.00 |
| 2023-05-19 | Romano Kelly A | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | JOHNSON JAMES A | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | Kosacz Barbara | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | EDELMAN JOSEPH | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | Panzara Michael A. | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | FLUKE JOHN M JR | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-19 | PICKERING GRANT | director | 20,900 | A-Award | A | 20,900 | 2.89 | 60,401.00 |
| 2023-05-18 | Gengos Andrew | officer: See Below | 400,000 | A-Award | A | 400,000 | 2.84 | 1,136,000.00 |
| 2023-05-18 | Gengos Andrew | officer: See Below | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-03-30 | PICKERING GRANT | director | 25,783 | P-Purchase | A | 15,000 | 2.47 | 37,050.00 |
| 2023-03-29 | PICKERING GRANT | director | 10,783 | P-Purchase | A | 10,000 | 2.33 | 23,300.00 |
| 2023-03-29 | JOHNSON JAMES A | director | 5,000 | P-Purchase | A | 5,000 | 2.40 | 12,000.00 |
| 2023-03-24 | CHURCH KEVIN | officer: Chief Scientific Officer | 68,462 | M-Exempt | A | 6,410 | 1.35 | 8,654.00 |
| 2023-03-24 | CHURCH KEVIN | officer: Chief Scientific Officer | 0 | M-Exempt | D | 6,410 | 1.35 | 8,654.00 |
| 2023-01-27 | Litton Mark James | director, officer: Chief Executive Officer | 425,000 | A-Award | A | 425,000 | 4.11 | 1,746,750.00 |
| 2022-11-18 | Litton Mark James | director, officer: Chief Executive Officer | 129,217 | A-Award | A | 662 | 2.74 | 1,814.00 |
| 2023-01-19 | Worthington Mark | officer: General Counsel | 150,000 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2023-01-19 | MOEBIUS HANS | officer: Chief Medical Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-01-19 | MILESON GLENNA | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2023-01-19 | Lenington Rachel | officer: Chief Operating Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-01-19 | CHURCH KEVIN | officer: Executive VP, Research | 150,000 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2022-11-18 | CHURCH KEVIN | officer: Executive VP, Research | 62,052 | A-Award | A | 657 | 2.74 | 1,800.00 |
| 2022-12-28 | MILESON GLENNA | officer: Chief Financial Officer | 159,930 | P-Purchase | A | 50,000 | 2.85 | 142,250.00 |
| 2022-11-18 | MILESON GLENNA | officer: Chief Financial Officer | 109,930 | A-Award | A | 763 | 2.74 | 2,091.00 |
| 2022-12-02 | Romano Kelly A | director | 38,315 | P-Purchase | A | 30,000 | 3.29 | 98,700.00 |
| 2022-11-15 | MOEBIUS HANS | officer: Chief Medical Officer | 65,836 | P-Purchase | A | 5,000 | 3.29 | 16,442.00 |
| 2022-10-28 | CHURCH KEVIN | officer: Executive VP, Research | 61,395 | M-Exempt | A | 3,700 | 1.35 | 4,995.00 |
| 2022-10-28 | CHURCH KEVIN | officer: Executive VP, Research | 6,410 | M-Exempt | D | 3,700 | 0.00 | 0.00 |
| 2022-10-13 | MOEBIUS HANS | officer: Chief Medical Officer | 60,836 | M-Exempt | A | 7,881 | 1.35 | 10,639.00 |
| 2022-10-13 | MOEBIUS HANS | officer: Chief Medical Officer | 7,882 | M-Exempt | D | 7,881 | 0.00 | 0.00 |
| 2022-06-30 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 4,797,278 | P-Purchase | A | 1,101,362 | 2.99 | 3,293,072.00 |
| 2022-06-29 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | 3,695,916 | P-Purchase | A | 270,000 | 2.99 | 807,300.00 |
| 2022-06-29 | EDELMAN JOSEPH | director: | 3,695,916 | P-Purchase | A | 270,000 | 2.99 | 807,300.00 |
| 2022-06-28 | MOEBIUS HANS | officer: Chief Medical Officer | 52,955 | P-Purchase | A | 10,000 | 2.88 | 28,800.00 |
| 2022-06-22 | Worthington Mark | officer: General Counsel | 21,711 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2022-06-22 | Worthington Mark | officer: General Counsel | 19,097 | S-Sale | D | 2,614 | 2.69 | 7,032.00 |
| 2022-06-22 | MOEBIUS HANS | officer: Chief Medical Officer | 42,955 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2022-06-22 | MILESON GLENNA | officer: Chief Financial Officer | 109,167 | S-Sale | D | 2,614 | 2.69 | 7,032.00 |
| 2022-06-22 | MILESON GLENNA | officer: Chief Financial Officer | 101,781 | A-Award | A | 1,721 | 7.06 | 12,150.00 |
| 2022-06-22 | Litton Mark James | officer: Chief Executive Officer | 136,515 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-06-22 | Litton Mark James | officer: Chief Executive Officer | 128,555 | S-Sale | D | 7,960 | 2.69 | 21,412.00 |
| 2022-05-18 | Litton Mark James | director, officer: Chief Executive Officer | 116,515 | A-Award | A | 757 | 7.06 | 5,344.00 |
| 2022-06-22 | Lenington Rachel | officer: Chief Operating Officer | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2022-06-22 | Lenington Rachel | officer: Chief Operating Officer | 5,807 | S-Sale | D | 4,193 | 2.69 | 11,279.00 |
| 2022-06-22 | CHURCH KEVIN | officer: Executive VP, Research | 60,309 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2022-06-22 | CHURCH KEVIN | officer: Executive VP, Research | 57,695 | S-Sale | D | 2,614 | 2.69 | 7,032.00 |
| 2022-06-08 | CHURCH KEVIN | officer: Executive VP, Research | 47,809 | A-Award | A | 243 | 7.06 | 1,716.00 |
| 2022-06-08 | CHURCH KEVIN | officer: Executive VP, Research | 10,110 | M-Exempt | D | 2,500 | 0.00 | 0.00 |
| 2022-05-20 | PICKERING GRANT | director: | 3,467 | A-Award | A | 3,467 | 0.00 | 0.00 |
| 2022-05-20 | PICKERING GRANT | director | 3,467 | A-Award | A | 3,467 | 8.93 | 30,960.00 |
| 2022-05-20 | Romano Kelly A | director: | 13,871 | A-Award | A | 13,871 | 0.00 | 0.00 |
| 2022-05-20 | Romano Kelly A | director | 13,871 | A-Award | A | 13,871 | 8.93 | 123,868.00 |
| 2022-05-20 | Kosacz Barbara | director: | 13,871 | A-Award | A | 13,871 | 0.00 | 0.00 |
| 2022-05-20 | Kosacz Barbara | director | 13,871 | A-Award | A | 13,871 | 8.93 | 123,868.00 |
| 2022-05-20 | EDELMAN JOSEPH | director: | 13,871 | A-Award | A | 13,871 | 0.00 | 0.00 |
| 2022-05-20 | EDELMAN JOSEPH | director | 13,871 | A-Award | A | 13,871 | 8.93 | 123,868.00 |
| 2022-05-20 | FLUKE JOHN M JR | director: | 13,871 | A-Award | A | 13,871 | 0.00 | 0.00 |
| 2022-05-20 | FLUKE JOHN M JR | director | 13,871 | A-Award | A | 13,871 | 8.93 | 123,868.00 |
| 2022-05-20 | JOHNSON JAMES A | director: | 13,871 | A-Award | A | 13,871 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
